Detection of Dengue Virus in Plasma of Patients in Nepal
NCT03620487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 643
Last updated 2023-02-14
Summary
To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples collected as part of a hospital-based multi-site study conducted in Nepal.
Conditions
- Dengue Fever
Sponsors & Collaborators
-
Tribhuvan University, Nepal
collaborator OTHER -
Karius, Inc.
lead INDUSTRY
Principal Investigators
-
Krishna Manandhar, PhD · Tribhuvan University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-26
- Primary Completion
- 2020-03-31
- Completion
- 2020-07-31
Countries
- Nepal
Study Locations
More Related Trials
-
Safety Study of Dengushield in Healthy Adults
NCT03883620 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Characterizing Humoral Immune Response to Mosquito Bites
NCT04478370 ·Status: COMPLETED ·Phase: NA
-
A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
NCT06060067 ·Status: COMPLETED ·Phase: PHASE3
-
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
NCT03641339 ·Status: COMPLETED ·Phase: NA
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
NCT06268691 ·Status: COMPLETED ·Phase: NA
-
Applying Wolbachia to Eliminate Dengue
NCT03055585 ·Status: TERMINATED ·Phase: NA
-
Clinical Evaluation of the FilmArray® Global Fever (GF) Panel
NCT02968355 ·Status: COMPLETED
-
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)
NCT06917001 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
NCT04619823 ·Status: RECRUITING ·Phase: NA
-
The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico
NCT02831699 ·Status: COMPLETED
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
NCT02639299 ·Status: RECRUITING
-
Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali
NCT02206451 ·Status: COMPLETED
-
A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)
NCT04514107 ·Status: COMPLETED ·Phase: NA
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
Immune Responses After Human Subject Challenge With Sand Fly Bites
NCT01289977 ·Status: COMPLETED
-
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
NCT03106714 ·Status: COMPLETED
-
Preventing the Spread of Malaria in Mali
NCT01360112 ·Status: COMPLETED
-
Testing a Biometric Identification System to Improve Malaria Vaccine Completion
NCT07261280 ·Status: RECRUITING ·Phase: NA
-
Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)
NCT02672228 ·Status: COMPLETED ·Phase: NA
-
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
NCT02569827 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)
NCT02932072 ·Status: COMPLETED
-
Spatial Repellents for Vector Control
NCT04795648 ·Status: COMPLETED ·Phase: NA
-
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
NCT01254422 ·Status: COMPLETED ·Phase: PHASE3